| Literature DB >> 17170753 |
K Miyata1, T Yasukawa, M Fukuda, T Takeuchi, K Yamazaki, K Sakumi, M Tamamori-Adachi, Y Ohnishi, Y Ohtsuki, Y Nakabeppu, S Kitajima, S Onishi, T Aso.
Abstract
Elongin A is a transcription elongation factor that increases the overall rate of mRNA chain elongation by RNA polymerase II. To gain more insight into the physiological functions of Elongin A, we generated Elongin A-deficient mice. Elongin A homozygous mutant (Elongin A(-/-)) embryos demonstrated a severely retarded development and died at between days 10.5 and 12.5 of gestation, most likely due to extensive apoptosis. Moreover, mouse embryonic fibroblasts (MEFs) derived from Elongin A(-/-) embryos exhibited not only increased apoptosis but also senescence-like growth defects accompanied by the activation of p38 MAPK and p53. Knockdown of Elongin A in MEFs by RNA interference also dramatically induced the senescent phenotype. A study using inhibitors of p38 MAPK and p53 and the generation of Elongin A-deficient mice with p53-null background suggests that both the p38 MAPK and p53 pathways are responsible for the induction of senescence-like phenotypes, whereas additional signaling pathways appear to be involved in the mediation of apoptosis in Elongin A(-/-) cells. Taken together, our results suggest that Elongin A is required for the transcription of genes essential for early embryonic development and downregulation of its activity is tightly associated with cellular senescence.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17170753 DOI: 10.1038/sj.cdd.4402067
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 15.828